Also, there were a number of other signaling molecules, EGFR in particular, that were more heavily phosphorylated in ERK inhibitor/GBM EV-treated astrocytes, suggesting that these altered signaling cascades may cause astrocytes to become more tumor-like. This evidence concerns the gene EGFR and neoplasm.